Scott Dalgleish - Chief Financial Officer at Oncology Institute, Inc.

Issuer-level insider activity

Role
Chief Financial Officer
Issuer ticker
TOI, TOIIW on Nasdaq, DFPH on OTC
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Scott Dalgleish since 18 Aug 2025

Reported holdings for Scott Dalgleish in Oncology Institute, Inc.

Form 4 holding Chief Financial Officer

Oncology Institute, Inc.

Security class
Stock Option (right to buy)
Shares / value
162,891
Estimated value
Report date
21 Mar 2022
Price
Ownership
Direct
Underlying class
Common stock
Underlying amount

Transaction history for Scott Dalgleish in Oncology Institute, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .